School of Dentistry, University of Granada, Granada, Spain; Biohealth Research Institute, Granada, Spain.
Faculty of Dental, Oral & Craniofacial Sciences, King's College London, London, UK; WHO Collaborating Centre for Oral Cancer, London, UK.
Oral Oncol. 2020 Jul;106:104688. doi: 10.1016/j.oraloncology.2020.104688. Epub 2020 Apr 16.
To evaluate current evidence in relation to the prognostic and clinicopathological significance of oral squamous cell carcinomas arising in patients with oral lichen planus (OLP-OSCC).
We searched PubMed, Embase, Web of Science and Scopus for studies published before May-2019. We evaluated the quality of studies (QUIPS tool). We carried out meta-analyses to fulfill our objective. We examined the between-study heterogeneity and small-study effects, and conducted sensitivity and subgroup analyses.
Inclusion criteria were met by 27 studies (10,505 patients with OLP, of whom 205 developed a total of 247 OSCCs). The combined 5-year mortality rate was 15.48% for OLP-OSCC (95%CI = 7.34-25.19), clearly lower than the 34.70-50.00% mortality rate for conventional oral cancer communicated in previous official reports. Also, 14.67% (95%CI = 6.34-24.81) of OLP-OSCC developed N+ status, compared to 47.00% of conventional oral carcinomas. Likewise, most of the OSCCs in the study were T1/T2 (93.57%, 95%CI = 82.20-99.88) and presented at stage I/II (81.51%, 95%CI = 68.32-92.38) at the time of diagnosis, which contrasts with 50.00% of conventional carcinomas diagnosed in stages I/II. Furthermore, most of the cases were grade I (well differentiated OSCC) (67.79%; 95%CI = 43.50-88.65), in comparison to conventional OSCCs, which present typically in grade II in 90.00% of cases. Our results also show an 11.21% of the OLP-OSCC patients in this study developed multiple tumors.
Oral squamous cell carcinomas that developed in oral lichen planus show favorable prognostic parameters, especially with regard to the mortality rate. Around 11% of OLP-OSCC patients develop multiple tumors, which confirms that OLP can lead to field cancerization.
评估口腔扁平苔藓(OLP)患者口腔鳞状细胞癌(OLP-OSCC)的预后和临床病理意义的现有证据。
我们在 PubMed、Embase、Web of Science 和 Scopus 中检索了截至 2019 年 5 月发表的研究。我们使用 QUIPS 工具评估了研究的质量。我们进行了荟萃分析以实现我们的目标。我们检查了研究之间的异质性和小样本效应,并进行了敏感性和亚组分析。
符合纳入标准的研究有 27 项(10505 例 OLP 患者,其中 205 例共发生 247 例 OSCC)。OLP-OSCC 的 5 年总死亡率为 15.48%(95%CI=7.34-25.19),明显低于之前官方报告中传统口腔癌的 34.70-50.00%死亡率。此外,OLP-OSCC 中 14.67%(95%CI=6.34-24.81)发生 N+状态,而传统口腔癌为 47.00%。同样,研究中的大多数 OSCC 为 T1/T2(93.57%,95%CI=82.20-99.88),且诊断时处于 I/II 期(81.51%,95%CI=68.32-92.38),而传统口腔癌中 I/II 期诊断的比例为 50.00%。此外,大多数病例为 I 级(分化良好的 OSCC)(67.79%;95%CI=43.50-88.65),而传统的 OSCC 通常为 90.00%的 II 级。我们的研究结果还显示,该研究中有 11.21%的 OLP-OSCC 患者发生了多灶性肿瘤。
口腔扁平苔藓中发生的口腔鳞状细胞癌显示出有利的预后参数,特别是死亡率。大约 11%的 OLP-OSCC 患者发生多灶性肿瘤,这证实了 OLP 可能导致区域性癌变。